Abiomed Inc (NASDAQ:ABMD) - Share price - Overview

Stock Report

Abiomed Inc ABMD

Last Price
$144.10

Day Change
-0.20|-0.14%

As of 21/07/2017
18:55:13 EDT | USD
Minimum 15 Minutes Delay.

Last Close144.30
Day Range142.91 - 145.20
Mkt Cap6.35Bil
52-Wk Range95.14 - 147.45
Yield %-
ISINUS0036541003
Volume290,782
P/E123.16
P/S14.45
P/CF55.90

Share Price

Financials
201520162017
More ...
Income Statement
Revenue230.31329.54445.30
Operating Income28.6765.1090.14
Net Income113.6938.1552.12
Basic EPS2.800.901.21
Avg. Diluted Shares Outstanding434545
Balance Sheet
Current Assets220.14288.39326.96
Non Current Assets118.23135.54223.46
Total Assets338.37423.93550.41
Current Liabilities39.3246.5469.62
Total Liabilities46.8155.1698.34
Total Equity291.56368.78452.07
Cash Flow
Operating Cash Flow43.2976.80115.12
Capital Expenditure-5.19-15.62-50.42
Free Cash Flow38.1061.1764.70

In millions, except "Basic EPS". Currency is USD.

Company Profile

Abiomed Inc is a medical device company. It provides mechanical circulatory support devices to aid heart recovery to heart failure patients.

Sector

Healthcare

Industry

Medical Devices

Stock Style

Mid-Growth

Fiscal Year Ends

March

Employees

908
Key Stats
More ...
Price/Earning TTM119.26
Price/Book14.07
Price/Sales TTM14.47
Rev Growth (3 year avg)34.35
EPS Growth (3 year avg)-
Operating Margin % TTM20.24
Net Margin % TTM11.70
ROE TTM12.70
Debt/Equity0.03
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.